Clearwater Analytics Q2 revenue $73.4M (+21% YoY); appoints Dr. JP Singh to board

Clearwater Analytics Holdings, Inc.

2022-Q2 EPS reported -$0.01 revenue$144,187,000

Revenue $73.4M, +20.6% YoY; net loss $2.2M vs $0.2M loss last year; non-GAAP net income $13.3M (+119% YoY).
Adjusted EBITDA $19.1M (26.0% margin); operating cash flow $18.3M; free cash flow $16.5M (87% conversion).
ARR $290.4M (+18.5% YoY); gross revenue retention 98% for 14 consecutive quarters; net retention 104% (down from 107%).
Q3 2022 revenue guided $74.5-75M; FY 2022 revenue $298-300M; adjusted EBITDA $79-81M.
Appointed Dr. JP Singh, Princeton CS professor and tech entrepreneur, to Board of Directors effective July 29, 2022.

item 2.02 item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Dr. JP Singh

Director

CWAN · Clearwater Analytics Holdings, Inc.

Effective: 2022-07-29
Filed: August 3, 2022, 7:59 PM ET

On July 29, 2022, the Board of Directors (the “Board”) of the Company increased the number of directors constituting the whole Board from eight to nine and appointed Dr. JP Singh to the Board, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Dr. JP Singh was appointed as Director at Clearwater Analytics Holdings, Inc..

Action: appointed
Role: Director

Exact text from the filing

On July 29, 2022, the Board of Directors (the “Board”) of the Company increased the number of directors constituting the whole Board from eight to nine and appointed Dr. JP Singh to the Board, effective immediately.

View on SEC.gov

Clearwater Analytics Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-22-014270

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.